Betacortril; Betacortril Forte

SECTION 2: Hazards identification

Appearance: White tablets

Signal word

WARNING

Hazard statements

Suspected of damaging the unborn child. May cause damage to adrenal gland through prolonged or repeated exposure.

Additional information

Short Term: Accidental ingestion may cause effects similar to those seen in clinical use. Known Clinical Effects: Drugs of this class may cause Cushing's syndrome, manifested by moon face, obesity, headache, acne, thirst, increased urination, impotence, menstrual irregularities, facial hair growth, and mental changes. Additionally, state of intense good feeling (euphoria), depression, adrenal suppression, gastrointestinal disturbances, lymphoid depletion, cataracts, increased intra-ocular pressure (glaucoma) may occur. EU Indication of danger: Toxic to Reproduction: Category 2 EU Hazard Symbols: EU Risk Phrases: R61 - May cause harm to the unborn child. Australian Hazard Classification

Hazardous Ingredients

Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.